icad Inc (ICAD)
1.45
-0.06
(-3.65%)
USD |
NASDAQ |
May 31, 16:00
1.46
+0.01
(+0.69%)
After-Hours: 20:00
icad SG&A Expense (Annual): 17.06M for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 17.06M |
| December 31, 2022 | 21.31M |
| December 31, 2021 | 25.54M |
| December 31, 2020 | 22.43M |
| December 31, 2019 | 21.08M |
| December 31, 2018 | 17.81M |
| December 31, 2017 | 18.38M |
| December 31, 2016 | 17.85M |
| December 31, 2015 | 21.19M |
| December 31, 2014 | 20.51M |
| December 31, 2013 | 16.69M |
| December 31, 2012 | 16.94M |
| December 31, 2011 | 23.68M |
| December 31, 2010 | 19.64M |
| December 31, 2009 | 18.39M |
| December 31, 2008 | 19.43M |
| December 31, 2007 | 17.96M |
| December 31, 2006 | 16.61M |
| Date | Value |
|---|---|
| December 31, 2005 | 15.10M |
| December 31, 2004 | 12.21M |
| December 31, 2003 | 9.278M |
| December 31, 2002 | 7.583M |
| December 31, 2001 | 2.688M |
| December 31, 2000 | 2.886M |
| December 31, 1999 | 3.00M |
| December 31, 1998 | 3.00M |
| December 31, 1997 | 3.40M |
| December 31, 1996 | 5.00M |
| December 31, 1995 | 6.00M |
| December 31, 1994 | 5.10M |
| December 31, 1993 | 8.00M |
| December 31, 1992 | 7.20M |
| December 31, 1991 | 8.80M |
| December 31, 1990 | 9.80M |
| December 31, 1989 | 7.70M |
| December 31, 1988 | 7.90M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
17.06M
Minimum
2023
25.54M
Maximum
2021
21.48M
Average
21.31M
Median
2022
SG&A Expense (Annual) Benchmarks
| Perspective Therapeutics Inc | 21.06M |
| ClearPoint Neuro Inc | 24.35M |
| Predictive Oncology Inc | 10.94M |
| Xtant Medical Holdings Inc | 64.29M |
| Asensus Surgical Inc | 36.08M |